West Nile encephalitis in 2 hematopoietic stem cell transplant recipients: Case series and literature review

被引:26
作者
Hong, DS
Jacobson, KL
Raad, II
de Lima, M
Anderlini, P
Fuller, GN
Ippoliti, C
Cool, RM
Leeds, NE
Narvios, A
Han, XY
Padula, A
Champlin, RE
Hosing, C
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Blood & Marrow Transplantat, Unit 423, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Infect Dis, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[4] Univ Texas, MD Anderson Canc Ctr, Dept Lab Med, Houston, TX 77030 USA
[5] Univ Texas, MD Anderson Canc Ctr, Dept Diagnost Radiol, Houston, TX 77030 USA
[6] Univ Texas, MD Anderson Canc Ctr, Dept Canc Med, Houston, TX 77030 USA
关键词
D O I
10.1086/378278
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Most human cases of West Nile virus infection are acquired via bites from an infected mosquito. In some cases, infection may also be transmitted by infected blood products or transplanted organs. There have been recent publications suggesting that chemotherapy and immunosuppression may increase a person's risks of developing central nervous system disease if the person is infected with the West Nile virus. Because patients undergoing hematopoietic stem cell transplantation not only are immunocompromised, but also receive multiple blood products, they are at a particularly high risk for acquiring symptomatic disease if exposed to the West Nile Virus. We describe here 2 patients who underwent hematopoietic transplantation at our institution and subsequently developed fatal West Nile virus infections.
引用
收藏
页码:1044 / 1049
页数:6
相关论文
共 23 条
[1]   Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro [J].
Anderson, JF ;
Rahal, JJ .
EMERGING INFECTIOUS DISEASES, 2002, 8 (01) :107-108
[2]  
[Anonymous], 2002, MMWR MORB MORTAL WKL, V51, P790
[3]  
[Anonymous], 2002, MMWR MORB MORTAL WKL, V51, P973
[4]   Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City [J].
Biggerstaff, BJ ;
Petersen, LR .
TRANSFUSION, 2002, 42 (08) :1019-1026
[5]   Characterization of imidazo[4,5-d]pyridazine nucleosides as modulators of unwinding reaction mediated by West Nile virus nucleoside triphosphatase/helicase:: Evidence for activity on the level of substrate and/or enzyme [J].
Borowski, P ;
Lang, M ;
Haag, A ;
Schmitz, H ;
Choe, J ;
Chen, HM ;
Hosmane, RS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) :1231-1239
[6]   West Nile virus [J].
Campbell, GL ;
Marfin, AA ;
Lanciotti, RS ;
Gubler, DJ .
LANCET INFECTIOUS DISEASES, 2002, 2 (09) :519-529
[7]  
Chowers MY, 2001, EMERG INFECT DIS, V7, P675
[8]   West Nile Virus [J].
Craven, RB ;
Roehrig, JT .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (06) :651-653
[9]   WEST NILE FEVER - THE CLINICAL FEATURES OF THE DISEASE AND THE ISOLATION OF WEST NILE VIRUS FROM THE BLOOD OF 9 HUMAN CASES [J].
GOLDBLUM, N ;
STERK, VV ;
PADERSKI, B .
AMERICAN JOURNAL OF HYGIENE, 1954, 59 (01) :89-103
[10]  
Hamdan A, 2002, Transpl Infect Dis, V4, P160, DOI 10.1034/j.1399-3062.2002.01014.x